Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCFL-BC in Advanced Colorectal Carcinoma with Resectable Metastases
NCT00513266Phase 2Unknown
- Sponsor
- Lausanne University Hospital
- Start
- Jun 2007
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab, cetuximab in colorectal cancer (metastatic) (mCRC), sponsored by Lausanne University Hospital. Status: unknown.
02
Drugs
bevacizumabcetuximab
03
Conditions
colorectal cancer (metastatic) (mCRC)
Beyond the preview
Go deeper on NCT00513266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00513266.